Showing results (2071-2080 of 2,503) with videos related to

Sort By:
Pageof 251
International Journal of Toxicology|November 1, 2013
Safety assessment of borosilicate glasses as used in cosmeticsLillian C Becker, Wilma F Bergfeld, Donald V Belsito, et al.
International Journal of Toxicology|December 20, 2015
Safety Assessment of Synthetic Fluorphlogopite as Used in CosmeticsLillian C Becker, Wilma F Bergfeld, Donald V Belsito, et al.
International Journal of Toxicology|August 1, 2015
Safety Assessment of Dialkyl Malates as Used in CosmeticsLillian C Becker, Wilma F Bergfeld, Donald V Belsito, et al.
Preventive Medicine|February 26, 2020
Association of prescription opioids and incident cardiovascular risk factors among post-9/11 VeteransPhilip W Chui, Kirsha S Gordon, James Dziura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 7, 2022
Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus ErythematosusYann L C Becker, Jean-Philippe Gagné, Anne-Sophie Julien, et al.
American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.
Plos Pathogens|August 25, 2020
High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanismsManja Czech-Sioli, Thomas Günther, Marlin Therre, et al.
Ebiomedicine|January 8, 2026
Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodentsChristian E Edvardsson, Louise Adermark, Sam Gottlieb, et al.
Cancers|June 16, 2019
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare CancerSophie Piperno-Neumann, Jose Maria Piulats, Matthias Goebeler, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
Pageof 251